The size of the Asia-Pacific surgical sutures market is predicted to grow to USD 1.1 Billion by 2029 from USD 0.84 Billion in 2024, registering a CAGR of 5.4% from 2024 to 2029.
The Asia Pacific, housing 8 million people, grapples with several chronic health challenges like diabetes, cancer, and respiratory problems. This region is experiencing a surge in surgical procedures, driven by improved healthcare infrastructure and increased accessibility to medical services. Approximately 3.7 billion individuals face the threat of significant health-related expenses linked to surgical interventions, with a disproportionate impact on regions such as sub-Saharan Africa and Southeast Asia. Due to these unfulfilled requirements and insufficient financial support, it is anticipated to leverage the market growth rate.
We are witnessing an increasing demand for environmentally friendly, biodegradable, and bioabsorbable sutures. This surge is attributed to the rising acceptance of minimally invasive surgical techniques, which provide precision and minimize tissue trauma. South and Southeast Asia face the second-highest unmet surgical demand, with more than 5600 cases per 100k population.The Asia Pacific region contends with elevated expenses related to surgical sutures attributed to sophisticated materials, manufacturing techniques, and stringent quality criteria. This factor is restraining the growth rate of the APAC surgical sutures market. Economic factors, competitive pricing, and tailored solutions all drive up costs. Effectively addressing these challenges entails striking a balance between maintaining high standards and optimizing costs in both production and distribution processes. One of the major challenges facing the APAC surgical sutures market is the limited access to healthcare in some regions. Challenges in the Asia Pacific Surgical Sutures Market encompass elevated expenses, alternative wound closure techniques, infection hazards, a predilection for minimally invasive procedures, rigorous regulatory clearances, restricted healthcare accessibility, a shortage of skilled professionals, environmental considerations, and economic limitations. Mitigating these issues requires a holistic approach that addresses cost factors, regulatory strategies, and environmental considerations.
The APAC surgical sutures market was influenced by the COVID-19 pandemic, witnessing heightened demand for COVID-19 treatment and emergency surgeries. Nevertheless, challenges emerged due to postponements, disruptions in the supply chain, financial pressures, and a focus on infectious disease control. Despite these challenges, the market is anticipated to rebound and experience growth in the post-pandemic period.
Sutures
Absorbable sutures
The Absorbable segment is leading with the largest shares of the APAC surgical sutures market. The market growth is propelled by the natural breakdown of absorbable sutures in the body and technological advancements such as improved tensile strength, reduced tissue reactivity, and controlled absorption rates. At the same time, the disposable segment is anticipated to grow at a steady rate due to the convenience and reduced infection risk.
The surgeries segment has a significant market share, whereas the general surgeries segment is also estimated to have a balanced growth rate during the forecast period. The growth in the surgeries segment can be attributed to factors such as population expansion, aging demographics, and advancements in surgical methodologies. Furthermore, the increasing desire for minimally invasive surgical approaches is impacting the need for sutures designed for smaller incisions and effective wound closure.
The hospital segment is ruling with the largest share of the market owing to the substantial number of surgical procedures conducted in hospitals, encompassing routine as well as intricate interventions, which consistently fuels the need for surgical sutures.
The expansion of the surgical sutures market is credited to governmental efforts directed toward improving healthcare accessibility and infrastructure.China's Surgical Sutures Market is leading with a dominant share as it is a prime contributor towards growth in the region. China is experiencing progress in technology and innovative developments in suture materials to meet the changing requirements of diverse surgical specialties.Japan's Surgical Sutures Market is growing at a faster rate during the forecast period. Japan's sophisticated healthcare system and stringent medical care standards contribute to a continual need for surgical sutures, especially given the aging population and prevalence of chronic diseases.South Korean Surgical Sutures Market is likely to have significant growth opportunities during the forecast period. The focus on cosmetic and plastic surgeries significantly impacts the requirement for sutures that improve aesthetic results.Singapore's Surgical Sutures Market is estimated to expand further in the coming years as the demand for sutures tailored to a diverse patient population is shaped by the influence of medical tourism.
Some of the most promising companies operating in the APAC Surgical Sutures Market profiled in this report are Johnson & Johnson Inc., B. Braun Melsungen AG, Smith & Nephew PLC, Demetech Corporation, Conmed Corporation, W.L. Gore & Associates, Boston Scientific Corporation, 3M Healthcare, Medtronic Inc., and Sutures India Pvt Ltd.
Frequently Asked Questions
Factors such as increasing incidences of chronic diseases, growing geriatric population, and increasing investments in the healthcare sector driving the surgical sutures market growth in the Asia-Pacific region.
The surgical sutures market in APAC is expected to grow at a CAGR of 5.4% from 2024 to 2029.
Ethicon, Medtronic, Smith & Nephew, B. Braun Melsungen AG are a few of the notable companies in the APAC surgical sutures market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region